Mark Eisner
Director/Board Member en The Genentech Foundation .
Fortuna: 375 805 $ al 31/03/2024
Perfil
El Dr. Mark Eisner, MD, es director médico de FibroGen, Inc. El Dr. Eisner fue anteriormente vicepresidente senior de Genentech, Inc. y profesor de la Universidad de California, San Francisco. Se licenció en la Universidad de Stanford, se doctoró en la Escuela de Salud Pública de la Universidad de Berkeley y se doctoró en el Centro Médico de la Universidad de Pensilvania.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
FIBROGEN, INC.
0.16% | 06/09/2023 | 159 917 ( 0.16% ) | 375 805 $ | 31/03/2024 |
Cargos activos de Mark Eisner
| Empresas | Cargo | Inicio |
|---|---|---|
| The Genentech Foundation | Director/Board Member | - |
Antiguos cargos conocidos de Mark Eisner.
| Empresas | Cargo | Fin |
|---|---|---|
| FIBROGEN, INC. | Chief Tech/Sci/R&D Officer | 08/09/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| The University of California, San Francisco | Corporate Officer/Principal | - |
Formación de Mark Eisner.
| Stanford University | Undergraduate Degree |
| UC Berkeley School of Public Health | Doctorate Degree |
| University of Pennsylvania Medical Center | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| The Genentech Foundation | Miscellaneous |
- Bolsa de valores
- Insiders
- Mark Eisner
